FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology
Posted:
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.
#Healthcare leaders, are you balancing #Interoperability & #DataPrivacy?
Direct EHR access offers benefits but also risks like breaches & revenue loss. Learn safeguards for secure data sharing.
Read more here.
Social care aims to improve the lives of people who need help in their daily living.
Join NIHR webinar to explore how research could improve care for: People experiencing homelessness, People with learning disabilities, People living with dementia.
Secure your…
Attendees
Sponsors and Exhibitors
Webinars
Contact us